Factors Associated With Preoperative Radiological Tumor Size Underestimation in Clinical T1-2 Breast Cancer Patients [0.03%]
临床T1-2期乳腺癌患者术前影像检查低估肿瘤体积的影响因素分析
Jungbin Kim,Yujin Lee,Sam-Youl Yoon et al.
Jungbin Kim et al.
Background: Accurate preoperative tumor size measurement is essential for determining optimal surgical margins in breast cancer patients. Thus, this study aimed to evaluate the factors associated with preoperative radiolo...
Ebrahim Babaee,Mahdi Soheyli,Nahid Nafissi
Ebrahim Babaee
Background: Breast cancer treatments, including chemotherapy, radiotherapy, endocrine therapy, targeted therapy, and surgical interventions, have significantly improved survival rates. However, these treatments are associ...
Exploratory Clinical Trial of Honghua Xiaoyao Pills for the Treatment of Liver Depression and Haemostasis-Type Hyperplasia of Mammary Glands: A Single-Centre, Single-Arm Study [0.03%]
逍遥解郁化痰乳癖丸治疗肝抑血瘀型乳腺增生症的探索性临床研究:单中心单臂试验
Li Zheng,Wei Liu,Jia-Ying Qiu et al.
Li Zheng et al.
Background: Hyperplasia of mammary glands (HMG) is a common benign disease of the female breast. Objective: This study aimed to observe...
Clinical Trial
The breast journal. 2026;2026(1):e3499662. DOI:10.1155/tbj/3499662 2026
HER2-Ultralow: Prevalence, Characteristics, and Treatment Choices Among Advanced Breast Cancer Patients With Tumors Initially Scored as IHC 0 [0.03%]
HER2-超低表达:初始免疫组化0分的晚期乳腺癌患者的患病率、特征及治疗选择
Anushree R Iyengar,Erinn P Downs,Sandhya Mehta et al.
Anushree R Iyengar et al.
Historically, HER2 status in invasive breast cancer has been categorized as HER2-positive (IHC 3+, IHC 2+/ISH+) or HER2-negative (IHC 0, IHC 1+, IHC 2+/ISH-). Patients meeting IHC 0 with membrane staining (HER2-ultralow) criteria may benefi...
Clinical Characteristics and Prognostic Risk Factors in Breast Cancer With Liver Metastasis [0.03%]
乳腺癌肝转移的临床特征和预后风险因素分析
Dandan Yu,Chengjun Zhu,Sujin Yang et al.
Dandan Yu et al.
Background: Liver metastasis is a key adverse prognostic factor in breast cancer patients. This research was aimed to assess the development, risk factors, and prognostic determinants of breast cancer liver metastasis (BC...
Effectiveness and Safety of Hypofractionated Radiotherapy in Patients With Ductal Carcinoma In Situ (DCIS) [0.03%]
对导管原位癌患者进行低分割放射治疗的有效性和安全性研究
Reza Samiee,Mohammadamin Kharaghani,Amirhossein Shahsavand et al.
Reza Samiee et al.
Objective: To synthesize the available evidence on the oncologic outcomes, toxicity, and cosmesis of hypofractionated whole-breast irradiation (HF-WBI) in patients with ductal carcinoma in situ (DCIS) following breast-con...
Expert Opinions on Postoperative Complications in Breast Cancer Surgery After Neoadjuvant Chemotherapy: A Descriptive Study Through Structured Interviews With Surgeons in Austria [0.03%]
新辅助化疗后乳腺癌手术并发症的专家意见:通过结构化访谈描述奥地利外科医生的观点
Carmen Leser,Rebecca Eisl,Georg Dorffner et al.
Carmen Leser et al.
Background: Neoadjuvant chemotherapy (NACT) is an important component in preparing breast cancer patients for surgery. Its impact on postoperative complications, such as wound infections and bleeding, remains unclear. Whi...
Development and Validation of a Cuproptosis-Based Risk Score Model for Predicting Neoadjuvant Chemotherapy Response in Breast Cancer: A Transcriptomic Analysis [0.03%]
基于杯状细胞凋亡的乳腺癌新辅助化疗反应预测风险评分模型的开发与验证:转录组分析
Lihai Zhang,Jiao Wang,Baihong Tan et al.
Lihai Zhang et al.
Objective: This study developed a cuproptosis-related transcriptomic risk score model to predict neoadjuvant chemotherapy (NAC) response in breast cancer (BC) patients and explored its association with the tumor immune mi...
Clinical Analysis of Comprehensive Pharmacotherapy Combined With Ultrasound-Guided Precise Lesion Resection Plus Primary Microplasty in the Treatment of Nonpuerperal Mastitis [0.03%]
超声引导下精准病灶切除联合微创修复术治疗非哺乳期乳腺炎的临床分析
Bao-Zhong Yao,Kun Peng,Sai-Long Sang et al.
Bao-Zhong Yao et al.
Objective: To explore the clinical efficacy, cosmetic outcome, and safety of comprehensive pharmacotherapy (traditional Chinese medicine + hormone + antibiotic) combined with ultrasound-guided precise lesion resection plu...
Akkermansia muciniphila-Driven ceRNA Networks Regulate Immune Modulation and Breast Cancer Progression [0.03%]
黏附分子艾克氏菌驱动的ceRNA网络调控免疫调节和乳腺癌进展
Uma Chaudhary,Arya A S,Mythili A
Uma Chaudhary
Background: Microbiota-derived metabolites are increasingly recognized as modulators of systemic immunity and cancer biology. This study investigates how a structurally distinct lipid from Akkermansia muciniphila influenc...